Han Yuan Li

age ~43

from Florence, SC

Get Report

Also known as:

Han Y Li
Yuan Han Li
Hanyuan Li
Li Han Yuan
Yuan Li Han
Han-Yuan Li
Li Hanyuan
Li Yuanhan

Connected to:

Han Li Phones & Addresses

Florence, SC
Raleigh, NC
Lake City, SC
Duluth, GA
Philadelphia, PA
1215 Stirling St, Philadelphia, PA 19111 • 2157385828

Work

Position:

Executive, Administrative, and Managerial Occupations

Education

Degree:

Bachelor's degree or higher

Emails

d***[email protected]

Resumes

Supervisor

view source

Location:

Florence, SC

Industry:

Chemicals

Work:

Nan Ya Plastics, America
Supervisor

Education:

Indiana University of Pennsylvania 2007 - 2009
Masters, Chemical Engineering National Taiwan University 2001 - 2005
Bachelors, Chemical Engineering

Skills:

Continuous Improvement
Manufacturing
Chemical Engineering
Process Improvement
Product Development
Microsoft Office

Han Li

view source

Han Li

view source

Han Li

view source

Han Li

view source

Location:

United States

Documentary Director

view source

Position:

Director at Science and Education Programming Center of CCTV

Location:

Beijing City, China

Industry:

Media Production

Work:

Science and Education Programming Center of CCTV - Beijing, China since Feb 2012
Director

Education:

Ohio University 2009 - 2011
Master of Arts (M.A.), Media Arts and Studies Rowan University 2006 - 2007
China University of Mining and Technology 2004 - 2008
Bachelor of Arts (B.A.), Broadcasting Journalism

Languages:

English
Chinese

Han Li

view source

Location:

United States

Han Li College Station, TX

view source

Work:

Computational Fluid Dynamic (CFD) Lab
Louisville, KY
May 2012 to May 2013
Research Assistant Duke University
Durham, NC
Jan 2012 to May 2012
Research Assistant ME331 Thermodynamics, Duke University

Mar 2011 to Mar 2012
Teaching Assistant North China Electric Power University
Baoding, China
Feb 2009 to Jun 2009
Research Assistant

Education:

Texas A&M University
College Station, TX
2013 to 2017
PhD in Mechanical Engineering Duke University
Durham, NC
2010 to 2012
M.S. in Mechanical Engineering North China Electric Power University
Baoding, CN
Sep 2006 to Jun 2010
B.Eng. in Mechanical Engineering

Skills:

ANSYS-FLUENT, ICEM-CFD, GAMBIT, ANSYS(Mechanical-APDL), ANSYS-CFX, Star-CCM+, Workbench, SolidWorks, AutoCAD, Tecplot, Abaqus, COMSOL; MATLAB, FORTRAN, C++, C#,

Lawyers & Attorneys

Han Li - Lawyer

view source

Office:

Li Thomas & Yu

ISLN:

919754698

Admitted:

1984

Han Li - Lawyer

view source

ISLN:

922867538

Admitted:

2008

University:

Fordham Law School

Han Li - Lawyer

view source

ISLN:

1000824912

Admitted:

2018

Medicine Doctors

Han Li

view source

Specialties:

Surgery

Isbn (Books And Publications)

Meng Ch'Iu: Famous Episodes from Chinese History and Legend

view source

Author
Han Li

ISBN #
0870112783

The Water Lily Pond: A Village Girls Journey in Maoist China

view source

Author
Han Z. Li

ISBN #
0889204314

Name / Title

Company / Classification

Phones & Addresses

Han S. Li
Manager, Managing

Southside Spa
Physical Fitness Facility

3733 Southside Blvd, Jacksonville, FL 32216
2855 Rolling Pin Ln, Suwanee, GA 30024
9049980890

Us Patents

Method For Diagnosing Neoplasia
view source
US Patent:

20030044861, Mar 6, 2003
Filed:

Apr 22, 2002
Appl. No.:

10/125823
Inventors:

Li Liu - North Wales PA, US
Bing Zhu - Mobile AL, US
Han Li - Yardley PA, US
W. Thompson - Doylestown PA, US
Gary Piazza - Doylestown PA, US
Rifat Pamukcu - Spring House PA, US
International Classification:

G01N033/574
G01N001/30
G01N033/48
US Classification:

435/007230, 435/040500
Abstract:

This invention provides a method for diagnosing a patient with neoplasia.

Packaged Pharmaceuticals And Methods For Causing Compounds And Pharmaceutical Compositions To Be Used As Inhibitors Of Neoplastic Lesions
view source
US Patent:

20030175833, Sep 18, 2003
Filed:

Sep 20, 2002
Appl. No.:

10/251165
Inventors:

Li Liu - Ambler PA, US
Bing Zhu - Mobile AL, US
Han Li - Yardley PA, US
W. Thompson - Doylestown PA, US
Rifat Pamukcu - Spring House PA, US
Gary Piazza - Doylestown PA, US
International Classification:

A61K031/00
G06F017/60
G01N033/574
US Classification:

435/007230, 514/001000, 705/003000
Abstract:

This invention provides pharmaceutical compositions containing compounds for the treatment of neoplasia in mammals. The phosphodiesterase inhibitory activity of a compound is determined along with COX inhibitory activity. Growth inhibitory and apoptosis inducing effects on cultured tumor cells are also determined. Compounds that exhibit phosphodiesterase inhibiton, growth inhibition and apoptosis induction, but prefereably not substantial prostaglandin inhibitory activity, are desirable for the treatment of neoplasia.

Methods For Treatment Of Diseases Where Gsk 3-Beta Is Desired, And Methods To Identify Compounds Usefule For That
view source
US Patent:

20030194750, Oct 16, 2003
Filed:

Apr 5, 2002
Appl. No.:

10/117255
Inventors:

Han Li - Yardley PA, US
W. Thompson - Doylestown PA, US
International Classification:

A61K031/00
G01N033/53
G01N033/567
C12Q001/48
US Classification:

435/007200, 435/015000, 514/001000
Abstract:

A method for selecting compounds for the treatment of diseases where GSK3 is desired includes assessing whether the compounds cause an increase in PKG activity in the tissue of interest.

Methods For Identifying Compounds For Inhibition Of Neoplastic Lesions, And Pharmacetical Compositions Containing Such Compounds
view source
US Patent:

20040009464, Jan 15, 2004
Filed:

Sep 24, 2002
Appl. No.:

10/253629
Inventors:

Li Liu - Ambler PA, US
Bing Zhu - Mobile AL, US
Han Li - Yardley PA, US
W. Thompson - Doylestown PA, US
Rifat Pamukcu - Springhouse PA, US
Gary Piazza - Doylestown PA, US
International Classification:

C12Q001/00
A61K031/60
A61K031/415
US Classification:

435/004000, 514/165000, 514/406000
Abstract:

This invention provides pharmaceutical compositions containing compounds for the treatment of neoplasia in mammals. The phosphodiesterase inhibitory activity of a compound is determined along with COX inhibitory activity. Growth inhibitory and apoptosis inducing effects on cultured tumor cells are also determined. Compounds that exhibit phosphodiesterase inhibiton, growth inhibition and apoptosis induction, but prefereably not substantial prostaglandin inhibitory activity, are desirable for the treatment of neoplasia.

Methods For Identifying Compounds For Inhibition Of Neoplastic Lesions, And Pharmaceutical Compositions Containing Such Compounds
view source
US Patent:

20050244914, Nov 3, 2005
Filed:

Jul 7, 2005
Appl. No.:

11/176073
Inventors:

Li Liu - Ambler PA, US
Bing Zhu - Mobile AL, US
Han Li - Yardley PA, US
W. Thompson - Doylestown PA, US
Rifat Pamukcu - Springhouse PA, US
Gary Piazza - Doylestown PA, US
International Classification:

C12Q001/42
A61K031/519
US Classification:

435021000, 514262100
Abstract:

This invention provides pharmaceutical compositions containing compounds for the treatment of neoplasia in mammals. The phosphodiesterase inhibitory activity of a compound is determined along with COX inhibitory activity. Growth inhibitory and apoptosis inducing effects on cultured tumor cells are also determined. Compounds that exhibit phosphodiesterase inhibiton, growth inhibition and apoptosis induction, but prefereably not substantial prostaglandin inhibitory activity, are desirable for the treatment of neoplasia.

Method Of Using A Novel Phosphodiesterase In Pharmaceutical Screeing To Identify Compounds For Treatment Of Neoplasia
view source
US Patent:

62007718, Mar 13, 2001
Filed:

Oct 15, 1998
Appl. No.:

9/173375
Inventors:

Li Liu - Northwales PA
Rifat Pamukcu - Spring House PA
W. Joseph Thompson - Doylestown PA
Gary A. Piazza - Doylestown PA
Han Li - Yardley PA
Bing Zhu - Mobile AL
Assignee:

Cell Pathways, Inc. - Hosham PA
International Classification:

C12Q 144
US Classification:

435 19
Abstract:

A method for identifying compounds useful for the treatment of neoplasia involves acertaining whether such compounds exhibit an ability to inhibit a PDE that is characterized by cGMP specificity, cooperative kinetic behavior and insensitivity to phosphorylation.